Summary of GILEAD SCIENCES INC

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain

          Officers.


Compensation Arrangement of Certain Officers

On November 4, 2009, the Compensation Committee of the Board of Directors of
Gilead Sciences, Inc. (the Company) approved the target bonus levels to be in
effect under the Company's Corporate Bonus Plan for the 2010 fiscal year for the
Company's current named executive officers (the Executive Officers). The target
bonus levels for the 2009 and 2010 fiscal years are summarized below:



Executive Officer                            2009 Target Bonus                   2010 Target Bonus
                                          (as a % of Base Salary)             (as a % of Base Salary)
John C. Martin                                                125 %                               130 %
   Chairman and Chief Executive
Officer

John F. Milligan                                               75 %                                90 %
   President and Chief Operating
Officer

Norbert W. Bischofberger                                       60 %                                70 %
   Executive Vice President,
Research and Development and
Chief Scientific Officer

Kevin Young                                                    60 %                                70 %
   Executive Vice President,
Commercial Operations

Gregg H. Alton                                                 60 %*                               70 %
   Executive Vice President,
Corporate and Medical Affairs

Robin L. Washington                                            55 %                                60 %
   Senior Vice President and
Chief Financial Officer

* In July 2009, in connection with Mr. Alton's appointment to serve as the Company's Executive Vice President, Corporate and Medical Affairs, the 2009 target bonus payable to him was increased from 55% of base salary to 60% of base salary. The amount of his 2009 target bonus will be prorated to reflect when he was promoted and moved to the higher target bonus.

The Company's Board of Directors ratified the target bonus level of Dr. Martin. No other terms have yet been established under the 2010 Corporate Bonus Plan for the Executive Officers.